Albaad (ALBA) AI Stock Analysis

• Market Cap: ₪574.53M
• Dividend Yield: 3.09%
• Average Volume (3M): 16.36K
• Price to Earnings (P/E): 9.6
• Beta (1Y): 0.50
• Revenue Growth: 1.75%
• EPS Growth: 5.26%
• Country: IL
• Employees: 1,670
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 93.80
• Shares Outstanding: 18,647,507
• 10 Day Avg. Volume: 13,562
• 30 Day Avg. Volume: 16,359
• PEG Ratio: 0.17
• Price to Book (P/B): 1.42
• Price to Sales (P/S): 0.38
• P/FCF Ratio: 11.92
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 63 Neutral
• Price Target: 3,281.00 ▼(-9.71% Downside)
• Action: Downgraded Date: 03/14/26
• Date: Action: Downgraded 03/14/26

Overall score reflects a mix of attractive valuation (low P/E and solid dividend) and improving operating performance, offset by elevated leverage and inconsistent cash-flow conversion, alongside weak technical momentum and a below-key-moving-averages price trend.

Positive Factors

Diversified revenue streams

Albaad's business spans finished disposable hygiene products and nonwoven materials sold to manufacturers, combining branded and private-label supply. This dual model creates recurring volume contracts, diversification of end markets and manufacturing scale, supporting steadier demand and margin resilience over months.

Accelerating revenue and improving margins

A sharp revenue jump in 2025 with higher operating and net margins signals operational leverage and better pricing or cost control. If sustained, this scale-driven improvement enhances cash generation, strengthens customer relationships via capacity utilization, and supports medium-term margin sustainability.

Improving return on equity

Higher ROE and a better leverage profile versus recent peaks indicate more efficient capital deployment and earnings recovery. Improved ROE supports internal funding for reinvestment or dividends and signals management progress on profitability and capital allocation over the medium term.

Negative Factors

Elevated leverage

A debt-to-equity ratio near 1.5x limits financial flexibility and raises refinancing and interest-rate exposure. Elevated leverage can constrain capital expenditures, dividend policy or strategic investments if demand softens, making the company more sensitive to cyclical pressures over several quarters.

Weakened cash conversion

Declining FCF conversion and choppy multi-year cash flow (including negative FCF in 2021–2022) point to variable working-capital needs or investment timing. Inconsistent cash conversion undermines the durability of earnings and increases reliance on debt or external funding for growth or payouts.

Earnings volatility and margin recovery risk

Historical net losses and margins below prior peaks indicate execution and cyclicality risks in the business. Such volatility reduces predictability of free cash flow and returns, complicating long-term planning and increasing the chance that temporary headwinds could persist or recur over multiple quarters.

Albaad Business Overview & Revenue Model

Company Description

Albaad Massuot Yitzhak Ltd produces and sells wipes worldwide. It offers cleaning hand wipes including disinfecting and antibacterial wipes; cosmetic wipes, such as facial care, body, and feet care wipes; feminine hygienic product, which include tampons; and baby, maternity, toddler, and household cleaning wipes. The company also provides professional wipes, such as para-medical, veterinary, automotive, and restaurant wipes, as well as sachets; adult wipes including adult bed and bath; personal care wipes, which include intimate wipes; para-pharma wipes and flushable moist toilet paper product. In addition, it offers contract, private label, and institutional manufacturing services. The company was founded in 1985 and is based in Nir Yitzhak, Israel.

How the Company Makes Money

Albaad makes money primarily by manufacturing and selling disposable hygiene products and nonwoven materials. Revenue is generated from (1) sales of finished hygiene products (e.g., baby diapers, adult incontinence products, and related disposable hygiene items) to retailers, distributors, and brand owners, including private-label supply arrangements where Albaad manufactures products that are sold under a customer’s brand; and (2) sales of nonwoven rolls/materials used as inputs in hygiene products, sold to other manufacturers and converters. Earnings are influenced by production volumes and capacity utilization, long-term or recurring supply relationships with large retail and consumer-products customers, and the spread between selling prices and key input costs (notably pulp and polymer-based raw materials), as well as operational efficiency and manufacturing scale. Specific partnership names, contract terms, customer concentration, and segment-level revenue splits: null.

Albaad Financial Statement Overview

Summary

Income statement is solid (strong 2025 revenue acceleration and improved profitability), but the balance sheet and cash flow are weaker: leverage remains elevated (debt-to-equity ~1.48x) and free cash flow conversion declined in 2025 with a choppy longer-term cash-flow history.

Income Statement

Revenue accelerated sharply in 2025 (up ~29.5% vs. near-flat growth in 2024), and profitability improved meaningfully versus 2023–2024 with higher operating and net margins. However, margins remain well below 2020 levels (peak profitability has not been regained), and the business showed earnings volatility earlier in the period with net losses in 2021–2022, highlighting cyclicality/execution risk.

Balance Sheet

Leverage remains elevated, with debt running higher than equity (2025 debt-to-equity ~1.48x), which can limit flexibility if conditions weaken. The positive offset is improving shareholder returns (return on equity rose to ~14.7% in 2025 from ~10.5% in 2024) and a better leverage profile than the 2022–2023 peak, but the capital structure is still meaningfully debt-leaning.

Cash Flow

Cash generation is positive with operating cash flow and free cash flow both positive in 2025, but free cash flow fell versus 2024 and converted to cash less efficiently relative to reported earnings (free cash flow was ~44% of net income in 2025 vs. ~67% in 2024). Longer-term trends are choppy (including negative free cash flow in 2021–2022), indicating variability in working capital and/or investment needs.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.76B	1.72B	1.71B	1.45B	1.49B
Gross Profit	349.10M	347.93M	344.37M	235.00M	270.70M
EBITDA	214.77M	192.42M	176.03M	78.18M	192.56M
Net Income	69.69M	44.88M	30.23M	-35.12M	-20.34M
Balance Sheet
Total Assets	1.50B	1.51B	1.58B	1.60B	1.57B
Cash, Cash Equivalents and Short-Term Investments	10.81M	25.16M	19.13M	27.19M	18.24M
Total Debt	702.17M	712.92M	829.03M	836.53M	802.11M
Total Liabilities	1.02B	1.07B	1.18B	1.24B	1.14B
Stockholders Equity	474.19M	426.68M	394.08M	346.83M	430.25M
Cash Flow
Free Cash Flow	56.34M	101.60M	120.98M	-67.58M	-38.08M
Operating Cash Flow	127.49M	152.50M	233.23M	18.57M	52.58M
Investing Cash Flow	-101.94M	-9.51M	-110.94M	-30.36M	-170.24M
Financing Cash Flow	-40.28M	-135.56M	-134.49M	20.46M	103.68M

Albaad Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3634.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:ALBA, the sentiment is Negative. The current price of 3634 is above the 20-day moving average (MA) of 3221.20, above the 50-day MA of 3364.18, and above the 200-day MA of 2669.13, indicating a neutral trend. The MACD of -79.88 indicates Positive momentum. The RSI at 31.52 is Neutral, neither overbought nor oversold. The STOCH value of 22.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:ALBA.

Albaad Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ALBA	63 Neutral	₪574.53M	9.63	―	3.09%	1.75%	5.26%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%